Intuitive Surgical submitted a next-generation flexible robotic endoscope to the FDA for 510(k) clearance, marking expansion into gastrointestinal care. The platform combines expertise from da Vinci surgical systems and Ion lung biopsy platform but remains in early development with no near-term revenue expected. Success will depend on regulatory approval, clinical evidence, and physician adoption.
STXS
Stereotaxis, Inc. · AMEX
News
1 latestNo direct coverage yet · Showing articles that mention STXS
Headlines link to the publisher. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Posts 24h
0
Replies 24h
0
Watchers
0
Board · $STXS · 0 threads
Sign in to post on $STXS
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.